146 related articles for article (PubMed ID: 10646842)
21. Role of RB and RB2/P130 genes in marrow stromal stem cells plasticity.
Jori FP; Napolitano MA; Melone MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
J Cell Physiol; 2004 Aug; 200(2):201-12. PubMed ID: 15174090
[TBL] [Abstract][Full Text] [Related]
22. Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach.
Tosi GM; Trimarchi C; Macaluso M; La Sala D; Ciccodicola A; Lazzi S; Massaro-Giordano M; Caporossi A; Giordano A; Cinti C
Oncogene; 2005 Sep; 24(38):5827-36. PubMed ID: 16007224
[TBL] [Abstract][Full Text] [Related]
23. p16 gene alterations in nasopharyngeal carcinoma.
Lo KW; Huang DP; Lau KM
Cancer Res; 1995 May; 55(10):2039-43. PubMed ID: 7743498
[TBL] [Abstract][Full Text] [Related]
24. Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer.
Alvi AJ; Hogg R; Rader JS; Kuo MJ; Maher ER; Latif F
Mol Pathol; 2002 Jun; 55(3):153-5. PubMed ID: 12032225
[TBL] [Abstract][Full Text] [Related]
25. Alterations of the retinoblastoma-related gene RB2/p130 in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Tsujiuchi T; Sasaki Y; Konishi Y; Tsutsumi M
Mol Carcinog; 2002 Oct; 35(2):57-62. PubMed ID: 12325035
[TBL] [Abstract][Full Text] [Related]
26. The retinoblastoma-related Rb2/p130 gene is an effector downstream of AP-2 during neural differentiation.
Paggi MG; Bonetto F; Severino A; Baldi A; Battista T; Bucci F; Felsani A; Lombardi D; Giordano A
Oncogene; 2001 May; 20(20):2570-8. PubMed ID: 11420667
[TBL] [Abstract][Full Text] [Related]
27. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
28. Retinoblastoma gene mutation in primary human renal cell carcinoma.
Shuin T; Torigoe S; Kubota Y; Kishida T; Hosaka M; Horikoshi T; Yao M; Kondo K; Sakai N; Danenberg K
Oncol Res; 1995; 7(2):63-6. PubMed ID: 7579728
[TBL] [Abstract][Full Text] [Related]
29. Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening.
Harbour JW
Ophthalmology; 1998 Aug; 105(8):1442-7. PubMed ID: 9709755
[TBL] [Abstract][Full Text] [Related]
30. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
Lo KW; Kwong J; Hui AB; Chan SY; To KF; Chan AS; Chow LS; Teo PM; Johnson PJ; Huang DP
Cancer Res; 2001 May; 61(10):3877-81. PubMed ID: 11358799
[TBL] [Abstract][Full Text] [Related]
31. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.
Brachman DG; Hallahan DE; Beckett MA; Yandell DW; Weichselbaum RR
Cancer Res; 1991 Dec; 51(23 Pt 1):6393-6. PubMed ID: 1933904
[TBL] [Abstract][Full Text] [Related]
32. A molecular study of first and second RB1 mutational hits in retinoblastoma patients.
de Andrade AF; da Hora Barbosa R; Vargas FR; Ferman S; Eisenberg AL; Fernandes L; Bonvicino CR
Cancer Genet Cytogenet; 2006 May; 167(1):43-6. PubMed ID: 16682285
[TBL] [Abstract][Full Text] [Related]
33. Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.
Milde-Langosch K; Goemann C; Methner C; Rieck G; Bamberger AM; Löning T
Br J Cancer; 2001 Aug; 85(4):546-51. PubMed ID: 11506494
[TBL] [Abstract][Full Text] [Related]
34. p53 mutation in human nasopharyngeal carcinomas.
Lo KW; Mok CH; Huang DP; Liu YX; Choi PH; Lee JC; Tsao SW
Anticancer Res; 1992; 12(6B):1957-63. PubMed ID: 1295443
[TBL] [Abstract][Full Text] [Related]
35. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
36. RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo.
Claudio PP; Stiegler P; Howard CM; Bellan C; Minimo C; Tosi GM; Rak J; Kovatich A; De Fazio P; Micheli P; Caputi M; Leoncini L; Kerbel R; Giordano GG; Giordano A
Cancer Res; 2001 Jan; 61(2):462-8. PubMed ID: 11212232
[TBL] [Abstract][Full Text] [Related]
37. Characterization of alterations of Rb2/p130 tumor suppressor in all-trans-retinoic acid resistant SK-OV3 ovarian carcinoma cells.
Fields AL; Soprano DR; Soprano KJ
J Cell Physiol; 2008 Oct; 217(1):77-85. PubMed ID: 18446820
[TBL] [Abstract][Full Text] [Related]
38. Genomic structure of the human retinoblastoma-related Rb2/p130 gene.
Baldi A; Boccia V; Claudio PP; De Luca A; Giordano A
Proc Natl Acad Sci U S A; 1996 May; 93(10):4629-32. PubMed ID: 8643454
[TBL] [Abstract][Full Text] [Related]
39. [The expression of tumor suppressor gene p53 and Rb gene in nasopharyngeal carcinoma].
Song Y; Wang L; Huang G; Huang R; Yuan S; Liu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):268-71. PubMed ID: 10684031
[TBL] [Abstract][Full Text] [Related]
40. [The status of p53 gene in the primary retinoblastoma].
Huang Q
Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):248-51. PubMed ID: 11835813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
